Mark A. Findeis Ph.D.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Dr. Mark A. Findeis, Ph.D. is a co-founder and served as Head of Research and Vice President of Research at Satori Pharmaceuticals Inc. Dr. Findeis helped to start TargeTech Incorporated and after the acquisition of TargeTech by The Immune Response Corporation, he joined Praecis Pharmaceuticals. Dr. Findeis served as Director of Chemistry of Praecis Pharmaceuticals and co-directed the discovery program that resulted in the beta-amyloid aggregation antagonist Apan for ...
281 Albany StreetPhone: 617-547-0022
Cambridge, Massachusetts 02139
Board Members Memberships*There is no Board Members Memberships data available.
Massachusetts Institute of Technology
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.